439O - A first in human, phase I trial of NP137, a first-in-class antibody targeting netrin-1, in patients with advanced refractory solid tumors.
Saved in:
| Title: | 439O - A first in human, phase I trial of NP137, a first-in-class antibody targeting netrin-1, in patients with advanced refractory solid tumors. |
|---|---|
| Authors: | Cassier, P.1 (AUTHOR), Eberst, L.1 (AUTHOR), Garin, G.2 (AUTHOR), Courbebaisse, Y.3 (AUTHOR), Terret, C.1 (AUTHOR), Robert, M.4 (AUTHOR), Frenel, J.-S.5 (AUTHOR), Depil, S.1 (AUTHOR), Delord, J.-P.6 (AUTHOR), Perol, D.7 (AUTHOR), Ray-Coquard, I.L.1 (AUTHOR), Bidaux, A.-S.8 (AUTHOR), Tabone-Eglinger, S.9 (AUTHOR), Gilles-Afchain, L.1 (AUTHOR), Treilleux, I.10 (AUTHOR), Wang, Q.11 (AUTHOR), Ducarouge, B.12 (AUTHOR), Mehlen, P.13 (AUTHOR), Blay, J.-Y.14 (AUTHOR), Gomez-Roca, C.A.15 (AUTHOR) |
| Source: | Annals of Oncology. 2019 Supplement 6, Vol. 30, pv159-v159. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152683081 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 439O - A first in human, phase I trial of NP137, a first-in-class antibody targeting netrin-1, in patients with advanced refractory solid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Cassier%2C+P%2E%22">Cassier, P.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Eberst%2C+L%2E%22">Eberst, L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garin%2C+G%2E%22">Garin, G.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Courbebaisse%2C+Y%2E%22">Courbebaisse, Y.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Terret%2C+C%2E%22">Terret, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Robert%2C+M%2E%22">Robert, M.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Frenel%2C+J%2E-S%2E%22">Frenel, J.-S.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Depil%2C+S%2E%22">Depil, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Delord%2C+J%2E-P%2E%22">Delord, J.-P.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Perol%2C+D%2E%22">Perol, D.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ray-Coquard%2C+I%2EL%2E%22">Ray-Coquard, I.L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bidaux%2C+A%2E-S%2E%22">Bidaux, A.-S.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tabone-Eglinger%2C+S%2E%22">Tabone-Eglinger, S.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gilles-Afchain%2C+L%2E%22">Gilles-Afchain, L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Treilleux%2C+I%2E%22">Treilleux, I.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Q%2E%22">Wang, Q.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ducarouge%2C+B%2E%22">Ducarouge, B.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mehlen%2C+P%2E%22">Mehlen, P.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Blay%2C+J%2E-Y%2E%22">Blay, J.-Y.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gomez-Roca%2C+C%2EA%2E%22">Gomez-Roca, C.A.</searchLink><relatesTo>15</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2019 Supplement 6, Vol. 30, pv159-v159. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152683081 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/annonc/mdz244.001 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: v159 Titles: – TitleFull: 439O - A first in human, phase I trial of NP137, a first-in-class antibody targeting netrin-1, in patients with advanced refractory solid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cassier, P. – PersonEntity: Name: NameFull: Eberst, L. – PersonEntity: Name: NameFull: Garin, G. – PersonEntity: Name: NameFull: Courbebaisse, Y. – PersonEntity: Name: NameFull: Terret, C. – PersonEntity: Name: NameFull: Robert, M. – PersonEntity: Name: NameFull: Frenel, J.-S. – PersonEntity: Name: NameFull: Depil, S. – PersonEntity: Name: NameFull: Delord, J.-P. – PersonEntity: Name: NameFull: Perol, D. – PersonEntity: Name: NameFull: Ray-Coquard, I.L. – PersonEntity: Name: NameFull: Bidaux, A.-S. – PersonEntity: Name: NameFull: Tabone-Eglinger, S. – PersonEntity: Name: NameFull: Gilles-Afchain, L. – PersonEntity: Name: NameFull: Treilleux, I. – PersonEntity: Name: NameFull: Wang, Q. – PersonEntity: Name: NameFull: Ducarouge, B. – PersonEntity: Name: NameFull: Mehlen, P. – PersonEntity: Name: NameFull: Blay, J.-Y. – PersonEntity: Name: NameFull: Gomez-Roca, C.A. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 10 Text: 2019 Supplement 6 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 30 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |